Rakuten Securities’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$691 Sell
11
-315
-97% -$21.9K ﹤0.01% 712
2025
Q4
$21.6K Buy
326
+249
+323% +$16.1K 0.01% 325
2025
Q3
$5.18K Buy
77
+65
+542% +$5.14K ﹤0.01% 509
2025
Q2
$1.05K Sell
12
-2
-14% -$157 ﹤0.01% 656
2025
Q1
$956 Sell
14
-49
-78% -$4K ﹤0.01% 669
2024
Q4
$4.9K Buy
63
+42
+200% +$3.11K ﹤0.01% 480
2024
Q3
$1.41K Buy
21
+10
+91% +$821 ﹤0.01% 539
2024
Q2
$1.25K Sell
11
-27
-71% -$3.41K ﹤0.01% 532
2024
Q1
$5.27K Buy
38
+14
+58% +$1.76K ﹤0.01% 395
2023
Q4
$2.98K Buy
+24
New +$2.45K ﹤0.01% 402

Other funds holding DXCM

Rakuten Securities's DXCM Position: Q1 2026 in Review

Rakuten Securities reduced its DexCom (DXCM) stake by 97% in Q1 2026, selling an estimated $21.9K and leaving 11 shares worth $691. The position accounts for ﹤0.01% of the portfolio, ranked #712.

Rakuten Securities first reported a position in DXCM in Q4 2023 and has held it in 10 quarters since. The position peaked at $21.6K in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Rakuten Securities held 11 shares of DexCom worth $691 as of Q1 2026.
  • Rakuten Securities sold 315 DexCom shares in Q1 2026, an estimated $21.9K.
  • DexCom made up ﹤0.01% of Rakuten Securities's portfolio in Q1 2026, its #712 holding.
  • Rakuten Securities first reported a position in DexCom in Q4 2023 and has held it in 10 quarters since.
  • Rakuten Securities's DexCom position peaked at $21.6K in Q4 2025.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Rakuten Securities's 13F filing for Q1 2026, filed 1 May 2026.